Nerve growth factor and striatal glutathione metabolism in a rat model of Huntington's disease

Restorative Neurology and Neuroscience

Volumn 17, Issue 4, 2000, Pages 217-221

  Cruz Aguado, R ^a   Turner, L F ^a   Diaz C M ^a   Pinero J ^a  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

Author keywords

Glutathione; Huntington's disease; Nerve growth factor; Oxidative stress; Quinolinic acid; Striatum

Indexed keywords

EXCITOTOXIN; GLUTATHIONE; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME ASSAY; GLUTATHIONE METABOLISM; HUNTINGTON CHOREA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0034437577     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Depletion of brain glutathione results in a decrease of glutathione reductase, an enzyme susceptible to oxidative damage
2. Huntington's disease
3. Asymmetrical behavior in rats following striatal lesions and fetal tranplants: The elevated body swing test
4. Glutathione in the brain: Disorders of glutathione metabolism
5. Quinolinic acid lesion induces changes in rat striatal glutathione metabolism
6. NGF prevents changes in rat brain glutathione-related enzymes following transection of the septohippocampal pathway
7. Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurons
8. Metabolism and functions of glutathione in brain
9. Hypoxic-ischemic brain injury and oxidative stress
10. Oxidative stress and antioxidant therapy in Parkinson's disease
11. Nerve growth factors in chick and rat tissues
12. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum
13. Selective sparing of a class of striatal neurons in Huntington's disease
14. Lesion of the nigrostriatal neurons by 6-hydroxydopamine induces changes in rat brain glutathione S-transferase
15. Molecular mechanisms for neurodegeneration
16. Differential alterations of NF-kappaB to oxidative stress in primary basal forebrain cultures
17. Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: Trophic effects upon cholinergic and noncholinergic striatal neurons
18. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracelular Ca2+ concentration, and neurotoxicity and increases antioxidant enzyme activities in hippocampal neurons
19. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage
20. A radical hypothesis for neurodegeneration
21. Role of nerve growth factor in oxidant homeostasis: Glutathione metabolism
22. Nuclear factor-B contributes to excitotoxin-induced apoptosis in rat striatum
23. Neurotransmitters and disorders of the basal ganglia
24. Signal transduction in neuronal death
25. Neurotrophic factors: Repair and regeneration in the central nervous system
26. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase mRNA
27. Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: Comparison between intraparenchymal and intraventricular administration